Tech Selloff Reverberates Through Global Markets
Global markets have been impacted by one of the steepest plunges in history as sentiment suddenly soured on the global AI buildout. Bloomberg's Anthony Stephens has the latest.
Every story in this category, newest first.
Global markets have been impacted by one of the steepest plunges in history as sentiment suddenly soured on the global AI buildout. Bloomberg's Anthony Stephens has the latest.
Shen Jianguang, VP and Chief Economist at JD.Com, shares his outlook on China's economy as the nation accelerates into an AI driven era marked by surging demand. He speaks with Bloomberg's Minmin Low on the sidelines of the World Economic Forum in Dalian, China on "Bloomberg: The Asia Trade".
Aurelia Metals (ASX:AMI) achieved financial close on its $150 million financing package to increase its available liquidity.
André Hoffmann, Co-Chair of the World Economic Forum, discusses his outlook for global growth and China's economy amid ongoing conflict in the Middle East and market volatility. He speaks with Bloomberg's Stephen Engle on the sidelines of the World Economic Forum in Dalian, China on "Bloomberg: The Asia Trade".
"It is going to be a process," US Treasury Secretary Scott Bessent says about the state of negotiations with Iran during remarks at the Economic Club of New York.
Baby Bunting Group (ASX:BBN) expects full-year pro forma net profit to reach $16 million to $17 million.
US Treasury Secretary Scott Bessent says economic statecraft policies will be guided in part by ensuring the nation addresses vulnerabilities to any adversary being able to curtail vital supplies. Bessent speaks at the Economic Club of New York.
Acrow (ASX:ACF) secured full underwriting for its $10 million share purchase plan to guarantee the capital raising target.
Tasmea (ASX:TEA) executed an agreement to acquire JPS Group for up to $75 million.
Iceni Gold (ASX:ICL) commenced a diamond drilling programme with a 350m deep angled hole at its priority Goose Well target.
The takeover timeline for Atlas Arteria (ASX:ALX) was extended after IFM Investors secured majority control.
AFT Pharmaceuticals (ASX:AFP) secured US FDA approval to launch a Phase 3 trial targeting a US$7.41 billion market.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy